Related Experiment Video
Updated: Aug 11, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[Chronic Chlamydia pneumonia infection in patients with chronic obstructive pulmonary disease]
E Mazur1, J Niedźwiadek, J Chmielewska-Badora
1Zakład Chorób Odzwierzecych Instytutu Medycyny Wsi w Lublinie.
Abstract:
The aim of our study was to evaluate the frequency of Chlamydia pneumoniae infection (especially chronic infection) in COPD patients. Microimmunofluorescence method has been applied Chlamydia pneumoniae Micro-IF test (Labsystems) has been used. The levels of specific IgG, IgA and IgM have been estimated in patients' serum. According to serologic criteria, 64.1% of COPD patients and 20.5% of healthy controls appeared to be chronically infected with Chlamydia pneumoniae (p < 0.001). Taking in account COPD severity, persistent Chlamydia pneumoniae infection has been present in 68.2%, 57.1%, and 50% of patients with severe, moderate and mild COPD, respectively. Our study has revealed that chronic Chlamydia pneumoniae infection occurs more frequently in COPD patients than in healthy controls and in patients with severe COPD than in ones with mild and moderate disease. It is possible that persistent Chlamydia pneumoniae infection can initiate or amplify inflammatory reactions in the respiratory tract. The results suggest a need to diagnose chronic Chlamydia pneumoniae infection in COPD patients and, if confirmed, to take an attempt of antimicrobial therapy.
Insights
Chronic Chlamydia pneumoniae infection is significantly more common in COPD patients than in healthy individuals. This persistent infection is also more prevalent in severe COPD cases, suggesting a potential link to respiratory inflammation.
Area of Science:
- Respiratory Medicine
- Infectious Diseases
- Microbiology
Context:
- Chronic Obstructive Pulmonary Disease (COPD) is a major global health concern.
- The role of persistent infections in COPD exacerbations and progression is increasingly recognized.
- Chlamydia pneumoniae is a potential respiratory pathogen implicated in various lung conditions.
Purpose:
- To determine the prevalence of chronic Chlamydia pneumoniae infection in patients with COPD.
- To compare infection rates between COPD patients and healthy controls.
- To investigate the association between COPD severity and chronic Chlamydia pneumoniae infection.
Summary:
- A microimmunofluorescence method was used to assess specific IgG, IgA, and IgM antibodies against Chlamydia pneumoniae in COPD patients and controls.
- Results showed chronic Chlamydia pneumoniae infection in 64.1% of COPD patients versus 20.5% of controls (p < 0.001).
- Prevalence was higher in severe COPD (68.2%) compared to moderate (57.1%) and mild (50%) COPD.
Impact:
- Chronic Chlamydia pneumoniae infection is significantly more frequent in COPD patients, particularly those with severe disease.
- Findings suggest persistent Chlamydia pneumoniae infection may initiate or exacerbate respiratory inflammation in COPD.
- The study highlights the importance of diagnosing and potentially treating chronic Chlamydia pneumoniae in COPD patients.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

